LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 111

Search options

  1. Article ; Online: Measles: a re-emerging problem in migrants and travellers.

    Heywood, Anita E

    Journal of travel medicine

    2018  Volume 25, Issue 1

    MeSH term(s) Adult ; Disease Outbreaks/prevention & control ; Disease Outbreaks/statistics & numerical data ; Emigrants and Immigrants/statistics & numerical data ; Europe ; Female ; Humans ; Latin America ; Measles/epidemiology ; Measles/prevention & control ; Measles Vaccine/administration & dosage ; Travel/statistics & numerical data ; United States
    Chemical Substances Measles Vaccine
    Language English
    Publishing date 2018-11-03
    Publishing country England
    Document type Editorial
    ZDB-ID 1212504-0
    ISSN 1708-8305 ; 1195-1982
    ISSN (online) 1708-8305
    ISSN 1195-1982
    DOI 10.1093/jtm/tay118
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Elimination of COVID-19: what would it look like and is it possible?

    Heywood, Anita E / Macintyre, C Raina

    The Lancet. Infectious diseases

    2020  Volume 20, Issue 9, Page(s) 1005–1007

    MeSH term(s) Betacoronavirus/physiology ; COVID-19 ; Coronavirus Infections/prevention & control ; Coronavirus Infections/virology ; Disease Eradication ; Humans ; Pandemics/prevention & control ; Pneumonia, Viral/prevention & control ; Pneumonia, Viral/virology ; SARS-CoV-2
    Keywords covid19
    Language English
    Publishing date 2020-08-06
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2061641-7
    ISSN 1474-4457 ; 1473-3099
    ISSN (online) 1474-4457
    ISSN 1473-3099
    DOI 10.1016/S1473-3099(20)30633-2
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: "It's no use saying it in English": A qualitative study exploring community leaders' perceptions of the challenges and opportunities with translating and interpreting COVID-19 related public health messaging to reach ethnic minorities in Australia.

    Seale, Holly / Harris-Roxas, Ben / Heywood, Anita E / Abdi, Ikram / Mahimbo, Abela / Woodland, Lisa / Waller, Emily

    PloS one

    2024  Volume 19, Issue 2, Page(s) e0284000

    Abstract: Background: The Australian Government implemented a range of public health response strategies and communication approaches to reduce the spread of COVID-19; however, concerns have been raised around a failure to sufficiently consider culturally and ... ...

    Abstract Background: The Australian Government implemented a range of public health response strategies and communication approaches to reduce the spread of COVID-19; however, concerns have been raised around a failure to sufficiently consider culturally and linguistically diverse (CaLD) communities in these processes. This research aimed to understand the factors that have impacted COVID-19 communication and engagement efforts during the pandemic from the perspective of key CaLD community and faith-based leaders. A further aim was to understand the processes that could be adopted to support future communication strategies, including promoting pandemic-related vaccines.
    Approach: This study included 29 key informant interviews with community and faith-based leaders in New South Wales, Australia.
    Results: The overwhelming message from community leaders was a sense of shared responsibility between their organisations and governments in communicating pertinent and accurate COVID-19 related information to CaLD communities. They expressed a sense of duty to keep their community members safe. However, community leaders and others shouldered significant costs related to resources and time that need to be acknowledged by governments in preparing for future disease outbreaks. They felt that governments should consider: 1) improving communication between governments and CaLD organisations; 2) responding to the specific CaLD needs with greater agility; 3) foregrounding social media in their communication strategy; 4) reinvesting in local public health units to know their population; 5) developing a health ambassadors model program; 6) preparing a hybrid model of translators/interpreters to fill the gap; and, 7) reimagining vaccine information campaigns to target CaLD communities better.
    Conclusion: Given the technical details about the COVID-19 virus conveyed in government information campaigns and the media, ensuring the most vulnerable populations, including people from CaLD backgrounds, access clear, concise and timely public health messaging from governments and community organisations requires further attention.
    MeSH term(s) Humans ; Australia/epidemiology ; Public Health ; COVID-19/epidemiology ; COVID-19/prevention & control ; Ethnic and Racial Minorities ; New South Wales
    Language English
    Publishing date 2024-02-29
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2267670-3
    ISSN 1932-6203 ; 1932-6203
    ISSN (online) 1932-6203
    ISSN 1932-6203
    DOI 10.1371/journal.pone.0284000
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Risk factors predicting the need for intensive care unit admission within forty-eight hours of emergency department presentation: A case-control study.

    Nasser, Ahmad / de Zwart, Blake J / Stewart, David J / Zielke, Anne M / Blazek, Katrina / Heywood, Anita E / Craig, Adam T

    Australian critical care : official journal of the Confederation of Australian Critical Care Nurses

    2024  

    Abstract: Background: Patients admitted from the emergency department to the wards, who progress to a critically unwell state, may require expeditious admission to the intensive care unit. It can be argued that earlier recognition of such patients, to facilitate ... ...

    Abstract Background: Patients admitted from the emergency department to the wards, who progress to a critically unwell state, may require expeditious admission to the intensive care unit. It can be argued that earlier recognition of such patients, to facilitate prompt transfer to intensive care, could be linked to more favourable clinical outcomes. Nevertheless, this can be clinically challenging, and there are currently no established evidence-based methods for predicting the need for intensive care in the future.
    Objectives: We aimed to analyse the emergency department data to describe the characteristics of patients who required an intensive care admission within 48 h of presentation. Secondly, we planned to test the feasibility of using this data to identify the associated risk factors for developing a predictive model.
    Methods: We designed a retrospective case-control study. Cases were patients admitted to intensive care within 48 h of their emergency department presentation. Controls were patients who did not need an intensive care admission. Groups were matched based on age, gender, admission calendar month, and diagnosis. To identify the associated variables, we used a conditional logistic regression model.
    Results: Compared to controls, cases were more likely to be obese, and smokers and had a higher prevalence of cardiovascular (39 [35.1%] vs 20 [18%], p = 0.004) and respiratory diagnoses (45 [40.5%] vs 25 [22.5%], p = 0.004). They received more medical emergency team reviews (53 [47.8%] vs 24 [21.6%], p < 0.001), and more patients had an acute resuscitation plan (31 [27.9%] vs 15 [13.5%], p = 0.008). The predictive model showed that having acute resuscitation plans, cardiovascular and respiratory diagnoses, and receiving medical emergency team reviews were strongly associated with having an intensive care admission within 48 h of presentation.
    Conclusions: Our study used emergency department data to provide a detailed description of patients who had an intensive care unit admission within 48 h of their presentation. It demonstrated the feasibility of using such data to identify the associated risk factors to develop a predictive model.
    Language English
    Publishing date 2024-04-06
    Publishing country Australia
    Document type Journal Article
    ZDB-ID 1159493-7
    ISSN 1878-1721 ; 1036-7314
    ISSN (online) 1878-1721
    ISSN 1036-7314
    DOI 10.1016/j.aucc.2024.01.012
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Trends in intravenous immunoglobulin use in New South Wales, Australia.

    Wood, James G / Heywood, Anita E / Dennington, Peta M / Lloyd, Andrew R / Ziegler, John B

    Internal medicine journal

    2023  Volume 54, Issue 1, Page(s) 149–156

    Abstract: Background: Intravenous immunoglobulin (IVIg) is a critical replacement therapy for immunodeficiencies and immunomodulatory treatment for autoimmune and inflammatory diseases. Adequate supply of IVIg is a global issue, necessitating supply restrictions. ...

    Abstract Background: Intravenous immunoglobulin (IVIg) is a critical replacement therapy for immunodeficiencies and immunomodulatory treatment for autoimmune and inflammatory diseases. Adequate supply of IVIg is a global issue, necessitating supply restrictions. In Australia, despite strict criteria for use, demand for IVIg has increased over time and exceeds domestic supply.
    Objective: Factors associated with the upward trend in overall IVIg use were examined, including in the number of unique patients, IVIg dosing and treatment frequency and variations by prescribing discipline and disease group.
    Methods: De-identified data of IVIg dispensed in the largest Australian state (New South Wales) from 2007 to 2013 were provided by Australian Red Cross Lifeblood. Trends and projections were calculated using log-linear regression of unique patients, treatment episodes and grams of IVIg for overall use and use stratified by discipline and disease group.
    Results: During the study period, 169 453 treatment episodes were recorded for 12 547 unique patients accounting for 5 827 787 g of IVIg use. Overall, IVIg use increased by 12.0% (11.5-12.6%) per year representing a 97.7% increase (91.6-104%) over the study period. The highest growth was among neurological conditions (16.0% (14.9-17.1%) per year). An increase in the number of unique patients was the primary driver of this growth, augmented by increases in the frequency and average dose per treatment.
    Conclusions: Clinically acceptable measures to improve management of IVIg supply are needed including optimising dose, frequency and duration of treatment. Formal evaluation of IVIg versus alternatives, including cost-effectiveness and comparative efficacy, is warranted.
    MeSH term(s) Humans ; Immunoglobulins, Intravenous/therapeutic use ; New South Wales/epidemiology ; Australia/epidemiology ; Plasma Exchange
    Chemical Substances Immunoglobulins, Intravenous
    Language English
    Publishing date 2023-07-24
    Publishing country Australia
    Document type Journal Article
    ZDB-ID 2045436-3
    ISSN 1445-5994 ; 1444-0903
    ISSN (online) 1445-5994
    ISSN 1444-0903
    DOI 10.1111/imj.16175
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Informing the design of a whole of life immunisation register for Australia.

    Kpozehouen, Elizabeth B / Heywood, Anita E / Menzies, Robert / Seale, Holly / Brotherton, Julia / Raina Macintyre, C

    Vaccine

    2023  Volume 41, Issue 19, Page(s) 3011–3018

    Abstract: Introduction: In 2016, Australia launched a whole life immunisation register, the Australian Immunisation Register (AIR), building on a universal childhood register established in 1997. Immunisation Information Systems are well established in Europe, ... ...

    Abstract Introduction: In 2016, Australia launched a whole life immunisation register, the Australian Immunisation Register (AIR), building on a universal childhood register established in 1997. Immunisation Information Systems are well established in Europe, the US and elsewhere. However, a national system covering immunisation across the lifespan, with complete capture of the population and satisfactory data quality, is rare.
    Methods: A national workshop was convened in 2016 with key stakeholders from the government, new and existing vaccine users, and vaccine providers to review the ideal features of the AIR to ensure optimal effectiveness. This workshop focused on the functionality needed to identify population groups newly included in the register and support the achievement of high immunisation coverage in these groups eligible for National Immunisation Program vaccines.
    Results: Key recommendations included the need for bidirectional data flow between the AIR and providers; systematic approaches to the capture and recording of accurate and complete data to ascertain important denominators for subpopulations, includingAboriginal and Torres Strait Islander status, medical risk factors, occupation, ethnicity, country of birth, and vaccines given during pregnancy; linkage with other government datasets including notifiable diseases; the capture of adverse events following immunisation; ease of access by patients, providers; and by researchers.
    Conclusions: Some recommendations from the workshop have informed the development and future utility of the AIR. Some recommendations from the workshop have been integrated into the current iteration of the AIR, which is more important than ever given the roll-out of COVID-19 vaccines. The accuracy and validity of data have subsequently improved through data entry controls, data integrity checks and reporting requirements. Access to AIR data for research remains protracted and costly, limitingresearch potential.
    MeSH term(s) Humans ; Child ; Australia/epidemiology ; COVID-19 Vaccines ; COVID-19/prevention & control ; Immunization ; Vaccines ; Immunization Programs
    Chemical Substances COVID-19 Vaccines ; Vaccines
    Language English
    Publishing date 2023-04-08
    Publishing country Netherlands
    Document type Clinical Conference
    ZDB-ID 605674-x
    ISSN 1873-2518 ; 0264-410X
    ISSN (online) 1873-2518
    ISSN 0264-410X
    DOI 10.1016/j.vaccine.2023.03.037
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Elimination of COVID-19

    Heywood, Anita E / Macintyre, C Raina

    The Lancet Infectious Diseases

    what would it look like and is it possible?

    2020  Volume 20, Issue 9, Page(s) 1005–1007

    Keywords Infectious Diseases ; covid19
    Language English
    Publisher Elsevier BV
    Publishing country us
    Document type Article ; Online
    ZDB-ID 2061641-7
    ISSN 1474-4457 ; 1473-3099
    ISSN (online) 1474-4457
    ISSN 1473-3099
    DOI 10.1016/s1473-3099(20)30633-2
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  8. Article ; Online: Measles epidemic in Samoa and other Pacific islands.

    Craig, Adam T / Heywood, Anita E / Worth, Heather

    The Lancet. Infectious diseases

    2020  Volume 20, Issue 3, Page(s) 273–275

    MeSH term(s) Disease Transmission, Infectious/prevention & control ; Epidemics ; Humans ; Incidence ; Measles/epidemiology ; Measles/mortality ; Measles/prevention & control ; Measles Vaccine/administration & dosage ; Measles Vaccine/immunology ; Pacific Islands/epidemiology ; Vaccination Coverage
    Chemical Substances Measles Vaccine
    Language English
    Publishing date 2020-03-25
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2061641-7
    ISSN 1474-4457 ; 1473-3099
    ISSN (online) 1474-4457
    ISSN 1473-3099
    DOI 10.1016/S1473-3099(20)30053-0
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Measles, mumps, rubella and varicella antibodies among international and domestic university students.

    Dyda, Amalie / Broome, Audrey / Rawlinson, William / Mahimbo, Abela / Saha, Amit / Kefalas, Bill / Seale, Holly / Macintyre, C Raina / Zwar, Nicholas / Gidding, Heather F / Heywood, Anita E

    Journal of travel medicine

    2024  Volume 31, Issue 1

    Abstract: Background: Vaccine-preventable infections are generally well controlled in Australia. However, gaps in immunity can lead to outbreaks and are important to identify. Young adults are a highly mobile population and a potential source of imported ... ...

    Abstract Background: Vaccine-preventable infections are generally well controlled in Australia. However, gaps in immunity can lead to outbreaks and are important to identify. Young adults are a highly mobile population and a potential source of imported infections. We aimed to evaluate anti- measles, mumps, rubella and varicella (MMR&V) IgG seroprevalence and explore factors relating to antibody seropositivity.
    Methods: A cross-sectional online survey was conducted among students from a large Australian university to collect demographic, vaccination, infection and travel characteristics. Blood samples were collected to measure MMR&V seroprevalence. Logistic regression was used to identify factors associated with seropositivity.
    Results: Among 804 university students, seroprevalence (positive or equivocal) for measles was 82.3% (95% CI 79.6-84.8%), mumps 79.5% (95% CI 76.7-82.3%), rubella 91.5% (95% CI 89.6-93.5%) and varicella 86.2% (95% CI 84.1-88.8%), with 452 (56.2%, 95% CI 52.8-59.6) seropositive to all four viruses. Varicella seropositivity was highest in the older birth cohort (born 1988-1991). Measles seropositivity was higher for international students compared to domestic students. Among international students, mumps seroprevalence was significantly lower than measles and rubella seroprevalence. International travel in the previous 12 months was reported by 63.1% of students, but only 18.2% of travellers reported seeking pre-travel health advice prior to most recent international travel.
    Conclusions: Overall, this study suggests immunity to MMR&V is sub-optimal. We found the university student population to be highly mobile and unlikely to seek pre-travel advice; thus, they are a potential source of infection importation. The implementation of university immunization policies could address the gaps identified and our findings can inform the development of targeted vaccination campaigns.
    MeSH term(s) Young Adult ; Humans ; Mumps/epidemiology ; Mumps/prevention & control ; Chickenpox/epidemiology ; Chickenpox/prevention & control ; Seroepidemiologic Studies ; Cross-Sectional Studies ; Universities ; Measles-Mumps-Rubella Vaccine ; Australia/epidemiology ; Rubella/epidemiology ; Rubella/prevention & control ; Measles/epidemiology ; Measles/prevention & control ; Students ; Antibodies, Viral ; Vaccination
    Chemical Substances Measles-Mumps-Rubella Vaccine ; Antibodies, Viral
    Language English
    Publishing date 2024-01-09
    Publishing country England
    Document type Journal Article
    ZDB-ID 1212504-0
    ISSN 1708-8305 ; 1195-1982
    ISSN (online) 1708-8305
    ISSN 1195-1982
    DOI 10.1093/jtm/taae004
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top